Phytochemicals against SARS-CoV as potential drug leads

Area of Science:

• Pharmacology
• Virology
• Computational Chemistry

Background:

• The emergence of SARS-CoV-2 has led to a global health crisis, necessitating rapid drug development.
• Repurposing existing drugs and exploring novel compounds like phytochemicals are key strategies.
• Phytochemicals, derived from plants, offer potential antiviral properties against coronaviruses.

Purpose of the Study:

• To systematically review and computationally analyze phytochemicals with reported anti-coronavirus activity.
• To identify promising lead compounds for SARS-CoV-2 drug development.
• To compare the efficacy of phytochemicals with existing repurposed drugs.

Main Methods:

• Systematic literature review of phytochemicals with anti-CoV activity (IC50 in μM).
• Cluster analysis to identify potent phytocompounds.
• Molecular docking simulations targeting the SARS-CoV-2 3CL protease.
• Comparison with FDA-approved drugs lopinavir and ritonavir.

Main Results:

• Seventy-eight phytochemicals with demonstrated anti-CoV activity were selected.
• Computational analysis identified several potent phytochemical candidates.
• Phytochemicals showed potential comparable to or exceeding that of repurposed drugs.

Conclusions:

• Phytochemicals represent a promising avenue for developing new antiviral therapies against SARS-CoV-2.
• Computational drug design can accelerate the validation and development of these natural compounds.
• Further research into phytochemical derivatives could lead to safe and effective treatments for COVID-19.